Delivery Order SPE2DB22D1002-SPE2DB24FLHD0

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,200.93 worth of Tresiba FlexTouch 200 unit/mL 3mL insulin products. The order has an ultimate completion date of April 8, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
This federal contract award is for the delivery of Tresiba FlexTouch 100 unit/mL 3mL, a prescription insulin product, to the Defense Logistics Agency (DLA). The $1,334.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 7, 2024, with a completion date of May 8, 2024. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA valued up to $999,999,999.00 through December...
This federal contract award is for the delivery of Tresiba FlexTouch insulin products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999. The contract has a ceiling value of $4,131.13 and an ultimate completion date of October 17, 2023. The contract is a firm fixed-price delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tresiba Flextouch 100 unit/mL 3mL, a prescription insulin product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $6,367.20, has a completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tresiba FlexTouch 200 unit/mL 3mL medication. The contract has a total ceiling value of $10,894.55 and a period of performance through July 1, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML insulin medication. The $18,948.75 firm-fixed-price contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tresiba FlexTouch 100 Unit/mL 3mL insulin medications. The $1,380.16 firm-fixed-price delivery order has an ultimate completion date of December 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,835.60 firm-fixed-price delivery order is for the supply of Tresiba Flextouch 200 unit/mL 3mL insulin products. This award is not designated as a set-aside contract. The contract has an ultimate completion date of September 11, 2024 and is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a $23,508.27 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,362,864 units of Tresiba FlexTouch 100 unit/mL 3mL, a prescription insulin product, with a performance period through August 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
The federal contract award is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $10,369.20 and is a firm-fixed-price delivery order with a completion date of January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLHD0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tresiba FlexTouch 200 Unit/mL 3mL insulin products. The contract has a ceiling value of $3,682.76 and spans from the award date of August 28, 2024, through the ultimate completion date of August 29, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, to provide a wide range of essential pharmaceutical and medical supplies to support various government healthcare programs and facilities, including military treatment centers and veterans' hospitals.

Generated 11/27/24, 9:20 AM